Device Trial Radar · NCT05064540
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
Last checked: Nov 20, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
450
Planned (sponsor's estimate)
Start
Sep 20, 2021
Primary completion
Mar 2032
Study completion Mar 2032
Sponsor
- Lead sponsor
- EndologixNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 1, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
Conditions
- AAA
- AAA - Abdominal Aortic Aneurysm
Interventions
Alto Abdominal Stent Graft SystemDevice
Endovascular Abdominal Aneurysm Repair (EVAR) using commercially available, FDA approved endovascular graft systems implanted.
FDA Approved EVAR AAA Graft SystemsDevice
FDA approved comparator of choice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Freedom from Aneurysm-Related Complications (ARC)Time frame: Through 5 years
- Neck Dilation in mmTime frame: Through 5 years
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Huntsville Hospital
Huntsville, Alabama · Active not recruiting
University of Arizona
Tucson, Arizona · Recruiting
Washington Regional Medical Center
Fayetteville, Arkansas · Recruiting
26 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.